Rainier Clinical Research Center

Rainier Clinical Research Center was compromised in a ransomware attack attributed to INCRANSOM in February 2026. The organization, operating in the Healthcare sector in United States, was added to the group's data leak site as part of an extortion campaign.

INCRANSOM operates as a financially motivated ransomware-as-a-service (RaaS) operation, exfiltrating sensitive data and threatening public disclosure to pressure victims into paying ransom demands.

Rainier Clinical Research Center is a leading research facility specializing in clinical trials for diabetes, medical devices, and high-volume studies, with over 700 studies completed in 30 years. The center provides a purpose-built 15,000 square-foot research space We will publish all the information next week.